1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6B703991E63A61F1885257F080071FA9D
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/B703991E63A61F1885257F080071FA9D!OpenDocument
18
19OpenDocument
203.239.58.199
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Digital Technology Digital Marketing Strategies

Document Excerpt: Best Practices in Biopharma Digital Marketing: Innovation Hotspots and Mobile Targeting

DB Image

ID: MD-491


Features:

6 Info Graphics

21 Data Graphics

250+ Metrics


Pages/Slides: 4


Published: Pre-2016


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click "
Download Free Excerpt".


To return to the study abstract to purchase the full study
- click here

This excerpt includes research findings and metrics from document #5390 "Best Practices in Biopharma Digital Marketing: Innovation Hotspots and Mobile Targeting."


Industries Profiled:
Pharmaceutical; Medical Device; Biotech; Manufacturing; Consumer Products; Diagnostic; Health Care; Biopharmaceutical; Clinical Research; Laboratories; Chemical; Marketing


Companies Profiled:
Novartis; Roche; Bayer; Mylan; Alcon; Eisai; Sanofi; Merck; Boehringer Ingelheim; Biogen; UCB Pharma; Hospira; Johnson & Johnson; GlaxoSmithKline ; Baxter Healthcare; Olympus Corporation; Sun Pharmaceutical; AstraZeneca; Abbvie; Genentech; Clarus Therapeutics; Zydus; Astellas; Bristol-Myers Squibb; Teva Pharmaceutical Industries Ltd; Ipsen; Abbott; Triplefin; cipla; Ferring Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.